Drug intelligence / Profile preview

nedocromil

Development stage
Approved
Lead developer
Sanofi
Modality
Small Molecules
Administration
Ophthalmic, Inhalation
01

Overview

Nedocromil is a small molecule anti-inflammatory agent classified as a mast cell stabilizer. It is used to prevent symptoms of asthma and allergic conjunctivitis. Inhaled nedocromil reduces the number and severity of asthma attacks by inhibiting the activation and degranulation of inflammatory cells such as mast cells, eosinophils, neutrophils, macrophages, monocytes, and platelets in the lungs. This prevents the release of mediators like histamine, leukotrienes, prostaglandins, and tryptase that contribute to airway inflammation and bronchospasm[1][2][5][7][9]. Ophthalmic formulations are used for allergic conjunctivitis by preventing mast cell degranulation in ocular tissues[3][10]. The drug does not provide relief for acute asthma or allergy attacks but is effective when used regularly as prophylaxis.

Brand names
TiladeAlocrilRapitil
Other names
nedocromil sodiumNédocromilNedocromiloNedocromilum

Beyond the preview

Go deeper on nedocromil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nedocromil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call